Chat with us, powered by LiveChat Zeneth: ICH Q1A(R2) Forced Degradation Study Design

How Zeneth Soft Spots Supports confident ICH Q1A(R2) Forced Degradation Study Design

Forced degradation study design that is both defensible and efficient requires insight into the specific reactivity of an API before work begins in the lab. For a structurally complex molecule, each ICH Q1A(R2) stress condition can implicate multiple functional groups and competing degradation pathways, the challenge is not generating predictions, but knowing which degradation sites to prioritise and why.

This post explains how the soft spots functionality introduced in Zeneth 10.2 (Lhasa Limited) addresses that challenge, mapping five computationally derived structural descriptors directly to ICH Q1A(R2) and ICH Q1B stress conditions to give analysts a structure-based starting point before experimental work begins.

Designing a forced degradation study that is both defensible and efficient requires insight into the specific reactivity of an API. The soft spots functionality of Zeneth provides that insight, mapping five computationally derived structural descriptors to the stress conditions required under ICH Q1A(R2) and ICH Q1B.

The prioritisation challenge in forced degradation

ICH Q1A(R2) requires oxidative, hydrolytic and thermal stress studies, with ICH Q1B adding photostability characterisation. For a structurally complex API, each stress condition can implicate multiple functional groups, multiple reactive sites, and competing degradation pathways, generating a substantial volume of prediction data that the analytical chemist must prioritise and interpret.

The question in study design is not “what could happen?” but “what is most likely to happen, and at which structural site?” Answering this question well means moving beyond a generic stress-testing protocol and towards adopting a study design informed by  specific API reactivity.

What are soft spots in forced degradation?

Soft spots are the structural regions of an API most susceptible to chemical reactivity under stress conditions.

Zeneth calculates five structural descriptors for each API, each targeting a different dimension of reactivity and mapping directly to one or more ICH stress conditions:

DescriptorICH stress conditionWhat it tells the analyst
Bond Dissociation EnergyICH Q1A(R2): oxidative, radical initiatorIdentifies the C-H bond most susceptible to radical abstraction, directing interpretation of the radical initiator study to the most probable initiation site
Fukui NucleophilicityICH Q1A(R2): oxidative, peroxideIdentifies the most nucleophilic Nitrogen or Sulphur, predicting the preferential site of electrophilic oxidation by peroxide
Fukui ElectrophilicityICH Q1A(R2): hydrolysis, acid and baseIdentifies the most electrophilic carbon, predicting the preferential site of nucleophilic attack under hydrolytic conditions
pKa / pKaHICH Q1A(R2): hydrolysis and oxidationShows the analyst where protonation or deprotonation is likely to occur which can influence reactivity and pH selection
Chromophore MappingICH Q1B: photostabilityIdentifies the largest conjugated system in the API, informing photostability risk and flagging potential analytical detection implications in degradants

The descriptors provide a structural reactivity map of the API, helping analysts to identify where degradation is most likely to be initiated and why.

The results are presented within the Zeneth workflow, where the full prediction set is filtered to the pathways most relevant to each structural area of concern.

How does this impact study design?

For the analytical chemist designing a forced degradation study, soft spots functionality changes how a prediction output is used.

Rather than working through a complete prediction set and applying experience-based judgement to prioritise the relevant degradants, the analyst has a computationally grounded starting point: a ranked view of structural reactivity across all ICH stress conditions, with the most probable degradation sites identified before experimental work begins.

As a result of using Zeneth 10.2, analysts can expect:

  • A more focused experimental plan and fewer redundant studies,
  • A clearer basis for the choice of stress conditions and concentrations
  • A direct route to identifying the degradants that need to be resolved in the stability-indicating method.

Supporting regulatory documentation

Regulatory submissions benefit from a clear scientific rationale for forced degradation study design. The soft spots analysis provides a documented, structure-based justification for why specific degradation pathways were prioritised, one that can be easily referenced in the analytical section of a regulatory submission.

Access and availability

Soft spots functionality is available to all current Zeneth members as part of their existing subscription. If you aren’t currently a member and would like to trial access, get in touch with our team.

Already a Zeneth member? Download Zeneth 10.2 to access the new features or book training.

What is in silico prediction in pharmaceutical development?

In silico prediction uses computational software to model chemical behaviour from molecular structure, without requiring physical samples or laboratory experiments. In pharmaceutical development, in silico tools are used to predict properties such as toxicity, solubility, metabolic stability, and, in the context of forced degradation studies, chemical reactivity under stress conditions. They are used alongside experimental methods to focus resources on the most probable outcomes for a given compound.

What is forced degradation testing in pharmaceuticals?

Forced degradation testing exposes an active pharmaceutical ingredient (API) to stress conditions including heat, light, oxidation, and hydrolysis to identify degradation pathways and support development of a stability-indicating analytical method. ICH Q1A(R2) sets out the stress conditions required for pharmaceutical stability studies.

What are soft spots in forced degradation study design?

Soft spots are the structural regions of an API predicted to be most reactive under specific stress conditions. Identifying soft spots before experimental work begins will help analysts to focus forced degradation studies on the most probable degradation pathways for that API structure, rather than applying a uniform protocol across all possible reactive sites.

What are the five structural descriptors calculated by Zeneth soft spots?

Zeneth calculates five structural descriptors, each mapped to a specific ICH stress condition:

  • Bond Dissociation Energy identifies the C–H bond most susceptible to radical abstraction (ICH Q1A(R2): oxidative, radical initiator)
  • Fukui Nucleophilicity identifies the most nucleophilic atom, predicting the preferential site of electrophilic oxidation by peroxide (ICH Q1A(R2): oxidative, peroxide)
  • Fukui Electrophilicity identifies the most electrophilic carbon, predicting the site of nucleophilic attack under hydrolytic conditions (ICH Q1A(R2): hydrolysis)
  • pKa / pKaH calculates ionisation state at study pH, contextualising reactivity predictions within the conditions of each stress experiment (ICH Q1A(R2): hydrolysis and oxidation)

Chromophore Mapping identifies the largest light-absorbing system in the API, informing photostability risk and flagging analytical detection implications for degradants (ICH Q1B: photostability)

How does soft spots functionality in Zeneth, support regulatory documentation?

Soft spots analysis provides a documented, structure-based justification for degradation pathway prioritisation in forced degradation studies. The output can be referenced in the analytical section of a regulatory submission to support the scientific rationale for study design under ICH Q1A(R2) and ICH Q1B, moving beyond a description of what was done to a clear explanation of why.

Is Zeneth soft spots included in Lhasa membership?

Yes. Soft spots functionality is available to all current Zeneth members as part of their existing subscription at no additional cost.

Last Updated on July 1, 2026 by lhasalimited

You may also like

by David Ponting, Senior Principal Scientist, Lhasa Limited On 24 September 2026, the US Food and Drug Administration (FDA) published a guidance …

As governments and regulators across the UK, EU and beyond move to reduce reliance on animal testing, the need for reliable and …

Nitrosamine qualification remains one of the most complex and fast-moving areas in pharmaceutical safety assessment. As scientific understanding advances and regulatory expectations …